Potiga ezogabine regulatory update

FDA approved an NDA from Valeant for Potiga ezogabine as an adjunctive treatment for partial onset seizures in adults. Valeant and partner GlaxoSmithKline expect to launch the product in the U.S. by year end. The

Read the full 352 word article

How to gain access

Continue reading with a
two-week free trial.